Cargando…

Amyotrophic Lateral Sclerosis After Exposure to Manganese from Traditional Medicine Procedures in Kenya

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by motor neuron loss and widespread muscular atrophy. Despite intensive investigations on genetic and environmental factors, the cause of ALS remains unknown. Recent data suggest a role for metal exposures in ALS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roos, Elin, Wärmländer, Sebastian K.T.S., Meyer, Jeremy, Sholts, Sabrina B., Jarvet, Jüri, Gräslund, Astrid, Roos, Per M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360856/ https://www.ncbi.nlm.nih.gov/pubmed/33230634 http://dx.doi.org/10.1007/s12011-020-02501-4

Ejemplares similares

Alzheimer’s disease and cigarette smoke components: effects of nicotine, PAHs, and Cd(II), Cr(III), Pb(II), Pb(IV) ions on amyloid-β peptide aggregation
por: Wallin, Cecilia, et al.
Publicado: (2017)

Mercury and Alzheimer’s Disease: Hg(II) Ions Display Specific Binding to the Amyloid-β Peptide and Hinder Its Fibrillization
por: Wallin, Cecilia, et al.
Publicado: (2019)

Mercury Ion Binding to Apolipoprotein E Variants ApoE2, ApoE3, and ApoE4: Similar Binding Affinities but Different Structure Induction Effects
por: Berntsson, Elina, et al.
Publicado: (2022)

Could the Health Decline of Prehistoric California Indians be Related to Exposure to Polycyclic Aromatic Hydrocarbons (PAHs) from Natural Bitumen?
por: Wärmländer, Sebastian K.T.S., et al.
Publicado: (2011)

Metal ion coordination delays amyloid-β peptide self-assembly by forming an aggregation–inert complex
por: Wallin, Cecilia, et al.
Publicado: (2020)

Risk factors for amyotrophic lateral sclerosis
por: Ingre, Caroline, et al.
Publicado: (2015)

Prion Protein Octarepeat Domain Forms Transient β-Sheet Structures upon Residue-Specific Binding to Cu(II) and Zn(II) Ions
por: Gielnik, Maciej, et al.
Publicado: (2023)

(13)C- and (15)N-labeling of amyloid-β and inhibitory peptides to study their interaction via nanoscale infrared spectroscopy
por: Paul, Suman, et al.
Publicado: (2023)

Residue-specific binding of Ni(II) ions influences the structure and aggregation of amyloid beta (Aβ) peptides
por: Berntsson, Elina, et al.
Publicado: (2023)

The amyloid-inhibiting NCAM-PrP peptide targets Aβ peptide aggregation in membrane-mimetic environments
por: Król, Sylwia, et al.
Publicado: (2021)

Characterization of Uranyl (UO(2)(2+)) Ion Binding to Amyloid Beta (Aβ) Peptides: Effects on Aβ Structure and Aggregation
por: Berntsson, Elina, et al.
Publicado: (2023)

Choosing an Optimal Solvent Is Crucial for Obtaining Cell-Penetrating Peptide Nanoparticles with Desired Properties and High Activity in Nucleic Acid Delivery
por: Biswas, Abhijit, et al.
Publicado: (2023)

Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009)

Evidence-Based Research Strategy of Traditional Chinese Medicine for Amyotrophic Lateral Sclerosis
por: Pan, Hao, et al.
Publicado: (2021)

Cell-Penetrating Peptides with Unexpected Anti-Amyloid Properties
por: Österlund, Nicklas, et al.
Publicado: (2022)

Amyotrophic lateral sclerosis and neuroregeneration
Publicado: (2012)

Mimickers of Amyotrophic Lateral Sclerosis
por: Dubey, Ayush, et al.
Publicado: (2019)

Destination Amyotrophic Lateral Sclerosis
por: Keon, Matt, et al.
Publicado: (2021)

Prionoids in amyotrophic lateral sclerosis
por: Gosset, Philippe, et al.
Publicado: (2022)

Amyotrophic lateral sclerosis and cerebellum
por: Kabiljo, Renata, et al.
Publicado: (2022)

Dysautonomia in Amyotrophic Lateral Sclerosis
por: Oprisan, Alexandra L., et al.
Publicado: (2023)

The role of pro-inflammatory S100A9 in Alzheimer’s disease amyloid-neuroinflammatory cascade
por: Wang, Chao, et al.
Publicado: (2013)

Beyond the Traditional Clinical Trials for Amyotrophic Lateral Sclerosis and The Future Impact of Gene Therapy
por: Cappella, Marisa, et al.
Publicado: (2021)

Traditional East Asian Herbal Medicine for Amyotrophic Lateral Sclerosis: A Scoping Review
por: Suh, Won Joo, et al.
Publicado: (2021)

Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis
por: Rizzo, Federica, et al.
Publicado: (2013)

Antecedent Disease and Amyotrophic Lateral Sclerosis: What Is Protecting Whom?
por: Hollinger, Sabrina K., et al.
Publicado: (2016)

POWERbreathe(®) Inspiratory Muscle Training in Amyotrophic Lateral Sclerosis
por: Vicente-Campos, Davinia, et al.
Publicado: (2022)

Clinical Psychology and Amyotrophic Lateral Sclerosis
por: Pagnini, Francesco, et al.
Publicado: (2010)

Glial Cells in Amyotrophic Lateral Sclerosis
por: Lasiene, Jurate, et al.
Publicado: (2011)

The Cortical Signature of Amyotrophic Lateral Sclerosis
por: Agosta, Federica, et al.
Publicado: (2012)

Redox Regulation in Amyotrophic Lateral Sclerosis
por: Parakh, Sonam, et al.
Publicado: (2013)

Genetics of amyotrophic lateral sclerosis: an update
por: Chen, Sheng, et al.
Publicado: (2013)

Protein aggregation in amyotrophic lateral sclerosis
por: Blokhuis, Anna M., et al.
Publicado: (2013)

Characteristics of pain in amyotrophic lateral sclerosis
por: Hanisch, Frank, et al.
Publicado: (2015)

Neuroimaging Endpoints in Amyotrophic Lateral Sclerosis
por: Menke, Ricarda A. L., et al.
Publicado: (2016)

Pemphigus vulgaris and amyotrophic lateral sclerosis
por: Mokhtari, Fatemeh, et al.
Publicado: (2016)

Metabolic Reprogramming in Amyotrophic Lateral Sclerosis
por: Szelechowski, M., et al.
Publicado: (2018)

Olfactory dysfunction in amyotrophic lateral sclerosis
por: Viguera, Cristina, et al.
Publicado: (2018)

RNA Dysregulation in Amyotrophic Lateral Sclerosis
por: Butti, Zoe, et al.
Publicado: (2019)

Biomarkers of Metabolism in Amyotrophic Lateral Sclerosis
por: Kirk, Siobhan E., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_c6fd6gc7r6an0bnkmi93ovr3um